Practical asymmetric synthesis of a γ-secretase inhibitor exploiting substrate-controlled intramolecular nitrile oxide-olefin cycloaddition

ORGN 801

Steven F. Oliver, steven_oliver@merck.com1, Jeremy P. Scott1, Karel M. J. Brands1, Sarah E. Brewer1, Antony J. Davies1, Andrew D. Gibb1, David Hands1, Stephen P. Keen1, Faye J. Sheen1, Robert D. Wilson1, Robert A. Reamer2, and Ulf-H. Dolling2. (1) Process Research, Merck Sharp and Dohme, Hertford Road, Hoddesdon, EN11 9BU, United Kingdom, (2) Process Research, Merck & Co., Inc, PO Box 2000, Rahway, NJ 07065
A practical asymmetric synthesis of the γ-secretase inhibitor (-)-1 is described. As the key transformation, a highly diastereoselective intramolecular nitrile oxide cycloaddition forms the hexahydrobenzisoxazole core of 2 in four operations. Other aspects of the route include a highly stereoselective reduction of an isoxazole to form a cis-γ-amino alcohol, an efficient chemical resolution, a dianion cyclization to construct a sultam ring, and the α-alkylation of a sultam with excellent diastereoselectivity. In each instance, the relative stereochemistry was evolved by way of substrate-based induction with ≥96% ds. Kilogram quantities of the targeted drug candidate (-)-1 were obtained, without recourse to chromatography, by way of 10 isolated intermediates and in 13% overall yield.

 

Total Synthesis, Materials, Molecular Recognition, Process R&D, and Physical Organic Chemistry
8:00 PM-10:00 PM, Wednesday, 13 September 2006 Moscone Center -- Hall D, Poster

Sci-Mix
8:00 PM-10:00 PM, Monday, 11 September 2006 Moscone Center -- Hall D, Sci-Mix

Division of Organic Chemistry

The 232nd ACS National Meeting, San Francisco, CA, September 10-14, 2006